Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Kurtis Reed

MOHS-Micrographic Surgery Twin Falls, ID Medical Doctor

NPI 1245484096 CMS profile 1252516

714 N College Rd, Suite A, Twin Falls, ID 83301

Open in the dashboard

General payments

$32

2 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Kurtis Reed of Twin Falls, ID is reported in the CMS Open Payments database as having received $32 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 3rd percentile of MOHS-Micrographic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $18 1
2019 General $14 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kurtis Reed
  • MOHS-Micrographic Surgery median
  • Middle half of MOHS-Micrographic Surgery
  • National median

In program year 2025, general payments to Kurtis Reed were reported at $0. Among 1,077 MOHS-Micrographic Surgery profiles paid that year, the median was $465 and the middle half received between $145 and $1,066.

Show as a table
Year Kurtis Reed MOHS-Micrographic Surgery median Middle half National median
2019 $14 $316 $106–$785 $163
2020 $0 $162 $68–$412 $114
2021 $0 $243 $87–$654 $132
2022 $0 $300 $102–$887 $149
2023 $18 $364 $125–$1,010 $160
2024 $0 $445 $142–$1,108 $164
2025 $0 $465 $145–$1,066 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AbbVie, Inc. $32 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $32 2 payments
Products named General payments · program years 2019–2023
  1. SKYRIZI $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

923

Median for Dermatology: 534

Drug cost

$334,898

Median for Dermatology: $67,151

Branded share of claims

13.8%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cosentyx (2 Syringes) Secukinumab Brand 31 $240,874
Otezla Apremilast Brand 14 $66,983
Fluocinonide Generic 118 $5,259
Fluorouracil Generic 30 $3,099
Metronidazole Generic 43 $2,815
Clobetasol Propionate Generic 59 $2,751
Tretinoin Generic 16 $2,105
Triamcinolone Acetonide Generic 167 $1,535
Dapsone Generic 16 $1,396
Hydroxychloroquine Sulfate Generic 16 $1,228

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 87 billing codes

Paid by Medicare

$319,666

Medicare's payments for the services billed

Medicare patients

1,132

Average age 77

Services billed

5,600

485 women, 647 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 41%
Diabetes 25%
Chronic kidney disease 22%
Ischemic heart disease 20%
Atrial fibrillation 19%
Cancer 16%
Depression 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other MOHS-Micrographic Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record